Neurogene Stock Forecast - Price Action Indicator
| NGNE Stock | 22.11 1.97 9.78% |
Neurogene Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Neurogene stock prices and determine the direction of Neurogene's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Neurogene's historical fundamentals, such as revenue growth or operating cash flow patterns.
Neurogene | Build AI portfolio with Neurogene Stock |
| Check Neurogene Volatility | Backtest Neurogene | Information Ratio |
Neurogene Trading Date Momentum
| On December 31 2025 Neurogene was traded for 22.11 at the closing time. The top price for the day was 22.24 and the lowest listed price was 19.84 . There was no trading activity during the period 0.0. Lack of trading volume on December 31, 2025 did not cause price change. The trading delta at closing time against the current closing price is 8.96% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Neurogene to competition |
Other Forecasting Options for Neurogene
For every potential investor in Neurogene, whether a beginner or expert, Neurogene's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neurogene Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neurogene. Basic forecasting techniques help filter out the noise by identifying Neurogene's price trends.Neurogene Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurogene stock to make a market-neutral strategy. Peer analysis of Neurogene could also be used in its relative valuation, which is a method of valuing Neurogene by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neurogene Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neurogene's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neurogene's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neurogene Market Strength Events
Market strength indicators help investors to evaluate how Neurogene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurogene shares will generate the highest return on investment. By undertsting and applying Neurogene stock market strength indicators, traders can identify Neurogene entry and exit signals to maximize returns.
Neurogene Risk Indicators
The analysis of Neurogene's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurogene's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurogene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.56 | |||
| Semi Deviation | 6.36 | |||
| Standard Deviation | 6.31 | |||
| Variance | 39.77 | |||
| Downside Variance | 42.24 | |||
| Semi Variance | 40.44 | |||
| Expected Short fall | (4.56) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Neurogene is a strong investment it is important to analyze Neurogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neurogene's future performance. For an informed investment choice regarding Neurogene Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Neurogene to cross-verify your projections. For information on how to trade Neurogene Stock refer to our How to Trade Neurogene Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurogene. If investors know Neurogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Neurogene is measured differently than its book value, which is the value of Neurogene that is recorded on the company's balance sheet. Investors also form their own opinion of Neurogene's value that differs from its market value or its book value, called intrinsic value, which is Neurogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurogene's market value can be influenced by many factors that don't directly affect Neurogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.